Dr. Michael J. Lazar

About Dr. Michael J. Lazar

Michael J. Lazar, M.D. graduated from the University of Arkansas in 1978 and completed postgraduate training in surgery and urology at LSU in 1983. He is four-time board certified by the American Board of Urology and is Managing Physician Director of Santa Rosa Surgical Management Co., LLC, which manages Santa Rosa Memorial Hospital’s Ambulatory Surgery Center. He is also Chairman of the Board of Directors of Redwood Health Services and is a member of the American Urological Association.

Dr. Lazar is married with 3 children, and has been active in Boy Scout leadership and coaching soccer. His hobbies include hiking, backpacking, camping, alpine skiing, and the occasional fly-fishing outing. Dr. Lazar also enjoys living in the wine country, which affords cultivation of a love of wine, and proximity to San Francisco allows enjoyment of its theater and fine arts.

Dr. Lazar and his staff are proud to be early leaders in the usage of HIFU, a medical procedure that applies high-intensity focused ultrasound energy to locally heat and destroy diseased or damaged tissue with prostate cancer through ablation. Dr. Lazar is working closely with SonaCare to bring this innovative service to Americans with this disease.

CMS Announces Increase To ASC Payment For HIFU Prostate Ablation

SonaCare Medical Reports That Medicare recognizes HIFU prostate ablation as a device-intensive procedure driving new ASC payment going into effect on or after October 1, 2017 CHARLOTTE, N.C., Sept. 20, 2017 SonaCare Medical, leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, is pleased to announce an increase in Medicare payment for prostate HIFU [...]

2017-12-13T13:37:18+00:00 November 14th, 2017|

Research News: Reduced Risk of Prostate Cancer in Men with Low Testosterone

Men with unusually low amounts of testosterone in their blood are around 20% less likely to develop prostate cancer, according to new research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool. Scientists from the University of Oxford conducted the largest analysis of hormones and prostate cancer risk to date. The study [...]

2017-12-13T13:37:18+00:00 November 8th, 2017|

New study reveals: Regret is lasting for many men who undergo traditional prostate cancer treatments

Responding to a recent review of patient comments spanning two decades Dr. Michael Lazar of California HIFU talks about the importance of informing prostate cancer patients about all available treatment options. A recent study revealed this month that as they get older, some men who have undergone treatment for prostate cancer come to regret the [...]

2017-12-13T13:37:18+00:00 October 23rd, 2017|

New research could lead to reduction in recurrence of prostate cancer

Recurrence of prostate cancer could be reduced thanks to exciting new discovery Ground breaking research could reduce the recurrence of prostate cancer in males, a new study in the journal Nature Communications reports. During this in depth study, an international team of researchers led by British scientists investigated the impact of anti-hormone therapy on samples [...]

2017-12-13T13:37:18+00:00 October 17th, 2017|

Prostate Cancer News: PSA screening significantly reduces the risk for death

After differences in implementation and settings were accounted for, two important prostate cancer screening trials provide compatible evidence that screening reduces prostate cancer mortality. After differences in implementation and settings were accounted for, two important prostate cancer screening trials provide compatible evidence that screening reduces prostate cancer mortality. These findings suggest that current guidelines recommending [...]

2017-12-13T13:37:19+00:00 October 11th, 2017|

Dr. Michael Lazar on September’s Prostate Cancer Awareness Campaign; Why Early Detection Saves Lives

Santa Rosa Urologist and Prostate cancer expert Dr. Michael Lazar provides an overview of prostate cancer screening options, and offers insight on a recent study suggesting that early detection saves lives. September is Prostate Cancer Awareness Month helping to put the spotlight on a very important topic; early treatment options. Second only to skin cancer, [...]

2017-12-13T13:37:19+00:00 September 20th, 2017|

Health Update Interview with Dr. Michael Lazar on iHeartRadio

Dr. Michael Lazar Interview on iHeart Radio Dr. Michael Lazar on HIFU for prostate cancer: In this Interview aired recently on iHeartRadio Dr. Lazar describes the many benefits of HIFU for early diagnosed prostate cancer.  "This is going to be a game-changer, without a doubt," says Dr. Lazar. Listen to the interview by [...]

2017-12-13T13:37:19+00:00 September 19th, 2017|

Dr. Lazar Health Update Interview on iHeartRadio

Dr. Michael Lazar Interview on iHeart Radio Dr. Michael Lazar on HIFU for prostate cancer: In this Interview aired recently on iHeartRadio Dr. Lazar describes the many benefits of HIFU for early diagnosed prostate cancer.  "This is going to be a game-changer, without a doubt," says Dr. Lazar. Listen to the interview by [...]

2017-12-13T13:37:19+00:00 September 19th, 2017|

California HIFU Shares Prostate Cancer Facts for National Prostate Cancer Month

September is National Prostate Cancer Awareness Month. Prostate cancer is the most common type of cancer among men in the US, other than skin cancer.  What are the symptoms of prostate cancer? Early prostate cancer usually causes no symptoms. Men who have prostate cancer can be symptom-free for years. But as it grows, prostate cancer can cause [...]

2017-12-13T13:37:19+00:00 September 12th, 2017|